Global Blood Tests for Alzheimer's Diagnosis Supply, Demand and Key Producers, 2026-2032
The global Blood Tests for Alzheimer's Diagnosis market size is expected to reach $ 131 million by 2032, rising at a market growth of 8.4% CAGR during the forecast period (2026-2032).
Blood Tests for Alzheimer's Diagnosis refer to diagnostic or biomarker testing methods that analyze Alzheimer's disease-related biomarkers in peripheral blood samples. These tests are designed to support the assessment of amyloid pathology, tau abnormalities, neurodegeneration, and neuroinflammation associated with Alzheimer's disease. Compared with cerebrospinal fluid testing and PET imaging, blood-based tests are less invasive, easier to perform, more accessible, and relatively more cost-effective. They are mainly used for diagnostic support in patients with cognitive impairment, clinical triage, treatment eligibility assessment, disease monitoring, and subject screening in drug development and clinical trials. The average price for end-point testing services is approximately US$500?900 per test.
The upstream supply chain of Blood Tests for Alzheimer's Diagnosis mainly includes antibodies, recombinant proteins, calibrators, quality controls, magnetic beads, enzyme labels, chemiluminescent substrates, assay raw materials, sample preparation consumables, chemiluminescent platforms, single-molecule immunoassay platforms, mass spectrometry systems, and related algorithms and data analysis software. The midstream segment consists of blood-based diagnostic product and platform companies that develop assays, instruments, and multi-biomarker panels targeting markers such as pTau, A?, NfL, GFAP, and ApoE. The downstream segment includes neurology departments, memory clinics, independent clinical laboratories, specialty testing centers, pharmaceutical companies, CROs, universities, and research institutions, with applications covering clinical diagnostic support, patient stratification, treatment monitoring, clinical trial enrollment, and Alzheimer?s disease biomarker research.
The Blood Tests for Alzheimer's Diagnosis market is entering a critical transition phase from research validation to clinical commercialization. With growing clinical evidence for blood-based biomarkers such as pTau, A?, NfL, and GFAP, and increasing demand for patient screening and stratification driven by anti-amyloid therapies, blood tests are expected to become an important supporting tool in the Alzheimer?s disease diagnostic pathway. Compared with PET imaging and cerebrospinal fluid testing, blood-based tests offer clear advantages in convenience, accessibility, and cost efficiency, making them particularly suitable for clinical triage, treatment eligibility assessment, and broader patient pre-screening. Future market growth will be driven by improvements in test accuracy, regulatory progress, physician adoption, laboratory channel expansion, and rising demand from drug development. However, the market still faces challenges related to clinical guideline adoption, reimbursement, assay standardization, and comparability across different technology platforms.
This report studies the global Blood Tests for Alzheimer's Diagnosis demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Blood Tests for Alzheimer's Diagnosis, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Blood Tests for Alzheimer's Diagnosis that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Blood Tests for Alzheimer's Diagnosis total market, 2021-2032, (USD Million)
Global Blood Tests for Alzheimer's Diagnosis total market by region & country, CAGR, 2021-2032, (USD Million)
U.S. VS China: Blood Tests for Alzheimer's Diagnosis total market, key domestic companies, and share, (USD Million)
Global Blood Tests for Alzheimer's Diagnosis revenue by player, revenue and market share 2021-2026, (USD Million)
Global Blood Tests for Alzheimer's Diagnosis total market by Type, CAGR, 2021-2032, (USD Million)
Global Blood Tests for Alzheimer's Diagnosis total market by Application, CAGR, 2021-2032, (USD Million)
This report profiles major players in the global Blood Tests for Alzheimer's Diagnosis market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Roche, Fujirebio, Sysmex, Shimadzu, Diadem, Quanterix, ALZpath, Beckman Coulter Diagnostics, Siemens Healthineers, Vazyme, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the world Blood Tests for Alzheimer's Diagnosis market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global Blood Tests for Alzheimer's Diagnosis Market, By Region:
1. How big is the global Blood Tests for Alzheimer's Diagnosis market?
2. What is the demand of the global Blood Tests for Alzheimer's Diagnosis market?
3. What is the year over year growth of the global Blood Tests for Alzheimer's Diagnosis market?
4. What is the total value of the global Blood Tests for Alzheimer's Diagnosis market?
5. Who are the Major Players in the global Blood Tests for Alzheimer's Diagnosis market?
6. What are the growth factors driving the market demand?
Blood Tests for Alzheimer's Diagnosis refer to diagnostic or biomarker testing methods that analyze Alzheimer's disease-related biomarkers in peripheral blood samples. These tests are designed to support the assessment of amyloid pathology, tau abnormalities, neurodegeneration, and neuroinflammation associated with Alzheimer's disease. Compared with cerebrospinal fluid testing and PET imaging, blood-based tests are less invasive, easier to perform, more accessible, and relatively more cost-effective. They are mainly used for diagnostic support in patients with cognitive impairment, clinical triage, treatment eligibility assessment, disease monitoring, and subject screening in drug development and clinical trials. The average price for end-point testing services is approximately US$500?900 per test.
The upstream supply chain of Blood Tests for Alzheimer's Diagnosis mainly includes antibodies, recombinant proteins, calibrators, quality controls, magnetic beads, enzyme labels, chemiluminescent substrates, assay raw materials, sample preparation consumables, chemiluminescent platforms, single-molecule immunoassay platforms, mass spectrometry systems, and related algorithms and data analysis software. The midstream segment consists of blood-based diagnostic product and platform companies that develop assays, instruments, and multi-biomarker panels targeting markers such as pTau, A?, NfL, GFAP, and ApoE. The downstream segment includes neurology departments, memory clinics, independent clinical laboratories, specialty testing centers, pharmaceutical companies, CROs, universities, and research institutions, with applications covering clinical diagnostic support, patient stratification, treatment monitoring, clinical trial enrollment, and Alzheimer?s disease biomarker research.
The Blood Tests for Alzheimer's Diagnosis market is entering a critical transition phase from research validation to clinical commercialization. With growing clinical evidence for blood-based biomarkers such as pTau, A?, NfL, and GFAP, and increasing demand for patient screening and stratification driven by anti-amyloid therapies, blood tests are expected to become an important supporting tool in the Alzheimer?s disease diagnostic pathway. Compared with PET imaging and cerebrospinal fluid testing, blood-based tests offer clear advantages in convenience, accessibility, and cost efficiency, making them particularly suitable for clinical triage, treatment eligibility assessment, and broader patient pre-screening. Future market growth will be driven by improvements in test accuracy, regulatory progress, physician adoption, laboratory channel expansion, and rising demand from drug development. However, the market still faces challenges related to clinical guideline adoption, reimbursement, assay standardization, and comparability across different technology platforms.
This report studies the global Blood Tests for Alzheimer's Diagnosis demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Blood Tests for Alzheimer's Diagnosis, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Blood Tests for Alzheimer's Diagnosis that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Blood Tests for Alzheimer's Diagnosis total market, 2021-2032, (USD Million)
Global Blood Tests for Alzheimer's Diagnosis total market by region & country, CAGR, 2021-2032, (USD Million)
U.S. VS China: Blood Tests for Alzheimer's Diagnosis total market, key domestic companies, and share, (USD Million)
Global Blood Tests for Alzheimer's Diagnosis revenue by player, revenue and market share 2021-2026, (USD Million)
Global Blood Tests for Alzheimer's Diagnosis total market by Type, CAGR, 2021-2032, (USD Million)
Global Blood Tests for Alzheimer's Diagnosis total market by Application, CAGR, 2021-2032, (USD Million)
This report profiles major players in the global Blood Tests for Alzheimer's Diagnosis market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Roche, Fujirebio, Sysmex, Shimadzu, Diadem, Quanterix, ALZpath, Beckman Coulter Diagnostics, Siemens Healthineers, Vazyme, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the world Blood Tests for Alzheimer's Diagnosis market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global Blood Tests for Alzheimer's Diagnosis Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- Single Biomarker Tests
- Multi-Biomarker Panel Tests
- Others
- Chemiluminescent Immunoassay
- Single-Molecule and Ultra-Sensitive Immunoassay
- Mass Spectrometry-Based Testing
- Others
- Clinical Use
- Non-Clinical Use
- Roche
- Fujirebio
- Sysmex
- Shimadzu
- Diadem
- Quanterix
- ALZpath
- Beckman Coulter Diagnostics
- Siemens Healthineers
- Vazyme
- Hoyotek
- BGI Genomics
- Kemei Diagnostics
- Maya Lightyear
1. How big is the global Blood Tests for Alzheimer's Diagnosis market?
2. What is the demand of the global Blood Tests for Alzheimer's Diagnosis market?
3. What is the year over year growth of the global Blood Tests for Alzheimer's Diagnosis market?
4. What is the total value of the global Blood Tests for Alzheimer's Diagnosis market?
5. Who are the Major Players in the global Blood Tests for Alzheimer's Diagnosis market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 Blood Tests for Alzheimer's Diagnosis Introduction
1.2 World Blood Tests for Alzheimer's Diagnosis Market Size & Forecast (2021 & 2025 & 2032)
1.3 World Blood Tests for Alzheimer's Diagnosis Total Market by Region (by Headquarter Location)
1.3.1 World Blood Tests for Alzheimer's Diagnosis Market Size by Region (2021-2032), (by Headquarter Location)
1.3.2 United States Based Company Blood Tests for Alzheimer's Diagnosis Revenue (2021-2032)
1.3.3 China Based Company Blood Tests for Alzheimer's Diagnosis Revenue (2021-2032)
1.3.4 Europe Based Company Blood Tests for Alzheimer's Diagnosis Revenue (2021-2032)
1.3.5 Japan Based Company Blood Tests for Alzheimer's Diagnosis Revenue (2021-2032)
1.3.6 South Korea Based Company Blood Tests for Alzheimer's Diagnosis Revenue (2021-2032)
1.3.7 ASEAN Based Company Blood Tests for Alzheimer's Diagnosis Revenue (2021-2032)
1.3.8 India Based Company Blood Tests for Alzheimer's Diagnosis Revenue (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 Blood Tests for Alzheimer's Diagnosis Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Major Market Trends
2 DEMAND SUMMARY
2.1 World Blood Tests for Alzheimer's Diagnosis Consumption Value (2021-2032)
2.2 World Blood Tests for Alzheimer's Diagnosis Consumption Value by Region
2.2.1 World Blood Tests for Alzheimer's Diagnosis Consumption Value by Region (2021-2026)
2.2.2 World Blood Tests for Alzheimer's Diagnosis Consumption Value Forecast by Region (2027-2032)
2.3 United States Blood Tests for Alzheimer's Diagnosis Consumption Value (2021-2032)
2.4 China Blood Tests for Alzheimer's Diagnosis Consumption Value (2021-2032)
2.5 Europe Blood Tests for Alzheimer's Diagnosis Consumption Value (2021-2032)
2.6 Japan Blood Tests for Alzheimer's Diagnosis Consumption Value (2021-2032)
2.7 South Korea Blood Tests for Alzheimer's Diagnosis Consumption Value (2021-2032)
2.8 ASEAN Blood Tests for Alzheimer's Diagnosis Consumption Value (2021-2032)
2.9 India Blood Tests for Alzheimer's Diagnosis Consumption Value (2021-2032)
3 WORLD BLOOD TESTS FOR ALZHEIMER'S DIAGNOSIS COMPANIES COMPETITIVE ANALYSIS
3.1 World Blood Tests for Alzheimer's Diagnosis Revenue by Player (2021-2026)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Blood Tests for Alzheimer's Diagnosis Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Blood Tests for Alzheimer's Diagnosis in 2025
3.2.3 Global Concentration Ratios (CR8) for Blood Tests for Alzheimer's Diagnosis in 2025
3.3 Blood Tests for Alzheimer's Diagnosis Company Evaluation Quadrant
3.4 Blood Tests for Alzheimer's Diagnosis Market: Overall Company Footprint Analysis
3.4.1 Blood Tests for Alzheimer's Diagnosis Market: Region Footprint
3.4.2 Blood Tests for Alzheimer's Diagnosis Market: Company Product Type Footprint
3.4.3 Blood Tests for Alzheimer's Diagnosis Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers & Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: Blood Tests for Alzheimer's Diagnosis Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Blood Tests for Alzheimer's Diagnosis Revenue Comparison (2021 & 2025 & 2032) (by Headquarter Location)
4.1.2 United States VS China: Blood Tests for Alzheimer's Diagnosis Revenue Market Share Comparison (2021 & 2025 & 2032)
4.2 United States Based Companies VS China Based Companies: Blood Tests for Alzheimer's Diagnosis Consumption Value Comparison
4.2.1 United States VS China: Blood Tests for Alzheimer's Diagnosis Consumption Value Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: Blood Tests for Alzheimer's Diagnosis Consumption Value Market Share Comparison (2021 & 2025 & 2032)
4.3 United States Based Blood Tests for Alzheimer's Diagnosis Companies and Market Share, 2021-2026
4.3.1 United States Based Blood Tests for Alzheimer's Diagnosis Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Blood Tests for Alzheimer's Diagnosis Revenue, (2021-2026)
4.4 China Based Companies Blood Tests for Alzheimer's Diagnosis Revenue and Market Share, 2021-2026
4.4.1 China Based Blood Tests for Alzheimer's Diagnosis Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Blood Tests for Alzheimer's Diagnosis Revenue, (2021-2026)
4.5 Rest of World Based Blood Tests for Alzheimer's Diagnosis Companies and Market Share, 2021-2026
4.5.1 Rest of World Based Blood Tests for Alzheimer's Diagnosis Companies, Headquarters (Province, Country)
4.5.2 Rest of World Based Companies Blood Tests for Alzheimer's Diagnosis Revenue (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World Blood Tests for Alzheimer's Diagnosis Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 Single Biomarker Tests
5.2.2 Multi-Biomarker Panel Tests
5.2.3 Others
5.3 Market Segment by Type
5.3.1 World Blood Tests for Alzheimer's Diagnosis Market Size by Type (2021-2026)
5.3.2 World Blood Tests for Alzheimer's Diagnosis Market Size by Type (2027-2032)
5.3.3 World Blood Tests for Alzheimer's Diagnosis Market Size Market Share by Type (2027-2032)
6 MARKET ANALYSIS COMMERCIALIZATION STATUS
6.1 World Blood Tests for Alzheimer's Diagnosis Market Size Overview Commercialization Status: 2021 VS 2025 VS 2032
6.2 Segment Introduction Commercialization Status
6.2.1 Chemiluminescent Immunoassay
6.2.2 Single-Molecule and Ultra-Sensitive Immunoassay
6.2.3 Mass Spectrometry-Based Testing
6.2.4 Others
6.3 Market Segment Commercialization Status
6.3.1 World Blood Tests for Alzheimer's Diagnosis Market Size Commercialization Status (2021-2026)
6.3.2 World Blood Tests for Alzheimer's Diagnosis Market Size Commercialization Status (2027-2032)
6.3.3 World Blood Tests for Alzheimer's Diagnosis Market Size Market Share Commercialization Status (2027-2032)
7 MARKET ANALYSIS BY APPLICATION
7.1 World Blood Tests for Alzheimer's Diagnosis Market Size Overview by Application: 2021 VS 2025 VS 2032
7.2 Segment Introduction by Application
7.2.1 Clinical Use
7.2.2 Non-Clinical Use
7.3 Market Segment by Application
7.3.1 World Blood Tests for Alzheimer's Diagnosis Market Size by Application (2021-2026)
7.3.2 World Blood Tests for Alzheimer's Diagnosis Market Size by Application (2027-2032)
7.3.3 World Blood Tests for Alzheimer's Diagnosis Market Size Market Share by Application (2021-2032)
8 COMPANY PROFILES
8.1 Roche
8.1.1 Roche Details
8.1.2 Roche Major Business
8.1.3 Roche Blood Tests for Alzheimer's Diagnosis Product and Services
8.1.4 Roche Blood Tests for Alzheimer's Diagnosis Revenue, Gross Margin and Market Share (2021-2026)
8.1.5 Roche Recent Developments/Updates
8.1.6 Roche Competitive Strengths & Weaknesses
8.2 Fujirebio
8.2.1 Fujirebio Details
8.2.2 Fujirebio Major Business
8.2.3 Fujirebio Blood Tests for Alzheimer's Diagnosis Product and Services
8.2.4 Fujirebio Blood Tests for Alzheimer's Diagnosis Revenue, Gross Margin and Market Share (2021-2026)
8.2.5 Fujirebio Recent Developments/Updates
8.2.6 Fujirebio Competitive Strengths & Weaknesses
8.3 Sysmex
8.3.1 Sysmex Details
8.3.2 Sysmex Major Business
8.3.3 Sysmex Blood Tests for Alzheimer's Diagnosis Product and Services
8.3.4 Sysmex Blood Tests for Alzheimer's Diagnosis Revenue, Gross Margin and Market Share (2021-2026)
8.3.5 Sysmex Recent Developments/Updates
8.3.6 Sysmex Competitive Strengths & Weaknesses
8.4 Shimadzu
8.4.1 Shimadzu Details
8.4.2 Shimadzu Major Business
8.4.3 Shimadzu Blood Tests for Alzheimer's Diagnosis Product and Services
8.4.4 Shimadzu Blood Tests for Alzheimer's Diagnosis Revenue, Gross Margin and Market Share (2021-2026)
8.4.5 Shimadzu Recent Developments/Updates
8.4.6 Shimadzu Competitive Strengths & Weaknesses
8.5 Diadem
8.5.1 Diadem Details
8.5.2 Diadem Major Business
8.5.3 Diadem Blood Tests for Alzheimer's Diagnosis Product and Services
8.5.4 Diadem Blood Tests for Alzheimer's Diagnosis Revenue, Gross Margin and Market Share (2021-2026)
8.5.5 Diadem Recent Developments/Updates
8.5.6 Diadem Competitive Strengths & Weaknesses
8.6 Quanterix
8.6.1 Quanterix Details
8.6.2 Quanterix Major Business
8.6.3 Quanterix Blood Tests for Alzheimer's Diagnosis Product and Services
8.6.4 Quanterix Blood Tests for Alzheimer's Diagnosis Revenue, Gross Margin and Market Share (2021-2026)
8.6.5 Quanterix Recent Developments/Updates
8.6.6 Quanterix Competitive Strengths & Weaknesses
8.7 ALZpath
8.7.1 ALZpath Details
8.7.2 ALZpath Major Business
8.7.3 ALZpath Blood Tests for Alzheimer's Diagnosis Product and Services
8.7.4 ALZpath Blood Tests for Alzheimer's Diagnosis Revenue, Gross Margin and Market Share (2021-2026)
8.7.5 ALZpath Recent Developments/Updates
8.7.6 ALZpath Competitive Strengths & Weaknesses
8.8 Beckman Coulter Diagnostics
8.8.1 Beckman Coulter Diagnostics Details
8.8.2 Beckman Coulter Diagnostics Major Business
8.8.3 Beckman Coulter Diagnostics Blood Tests for Alzheimer's Diagnosis Product and Services
8.8.4 Beckman Coulter Diagnostics Blood Tests for Alzheimer's Diagnosis Revenue, Gross Margin and Market Share (2021-2026)
8.8.5 Beckman Coulter Diagnostics Recent Developments/Updates
8.8.6 Beckman Coulter Diagnostics Competitive Strengths & Weaknesses
8.9 Siemens Healthineers
8.9.1 Siemens Healthineers Details
8.9.2 Siemens Healthineers Major Business
8.9.3 Siemens Healthineers Blood Tests for Alzheimer's Diagnosis Product and Services
8.9.4 Siemens Healthineers Blood Tests for Alzheimer's Diagnosis Revenue, Gross Margin and Market Share (2021-2026)
8.9.5 Siemens Healthineers Recent Developments/Updates
8.9.6 Siemens Healthineers Competitive Strengths & Weaknesses
8.10 Vazyme
8.10.1 Vazyme Details
8.10.2 Vazyme Major Business
8.10.3 Vazyme Blood Tests for Alzheimer's Diagnosis Product and Services
8.10.4 Vazyme Blood Tests for Alzheimer's Diagnosis Revenue, Gross Margin and Market Share (2021-2026)
8.10.5 Vazyme Recent Developments/Updates
8.10.6 Vazyme Competitive Strengths & Weaknesses
8.11 Hoyotek
8.11.1 Hoyotek Details
8.11.2 Hoyotek Major Business
8.11.3 Hoyotek Blood Tests for Alzheimer's Diagnosis Product and Services
8.11.4 Hoyotek Blood Tests for Alzheimer's Diagnosis Revenue, Gross Margin and Market Share (2021-2026)
8.11.5 Hoyotek Recent Developments/Updates
8.11.6 Hoyotek Competitive Strengths & Weaknesses
8.12 BGI Genomics
8.12.1 BGI Genomics Details
8.12.2 BGI Genomics Major Business
8.12.3 BGI Genomics Blood Tests for Alzheimer's Diagnosis Product and Services
8.12.4 BGI Genomics Blood Tests for Alzheimer's Diagnosis Revenue, Gross Margin and Market Share (2021-2026)
8.12.5 BGI Genomics Recent Developments/Updates
8.12.6 BGI Genomics Competitive Strengths & Weaknesses
8.13 Kemei Diagnostics
8.13.1 Kemei Diagnostics Details
8.13.2 Kemei Diagnostics Major Business
8.13.3 Kemei Diagnostics Blood Tests for Alzheimer's Diagnosis Product and Services
8.13.4 Kemei Diagnostics Blood Tests for Alzheimer's Diagnosis Revenue, Gross Margin and Market Share (2021-2026)
8.13.5 Kemei Diagnostics Recent Developments/Updates
8.13.6 Kemei Diagnostics Competitive Strengths & Weaknesses
8.14 Maya Lightyear
8.14.1 Maya Lightyear Details
8.14.2 Maya Lightyear Major Business
8.14.3 Maya Lightyear Blood Tests for Alzheimer's Diagnosis Product and Services
8.14.4 Maya Lightyear Blood Tests for Alzheimer's Diagnosis Revenue, Gross Margin and Market Share (2021-2026)
8.14.5 Maya Lightyear Recent Developments/Updates
8.14.6 Maya Lightyear Competitive Strengths & Weaknesses
9 INDUSTRY CHAIN ANALYSIS
9.1 Blood Tests for Alzheimer's Diagnosis Industry Chain
9.2 Blood Tests for Alzheimer's Diagnosis Upstream Analysis
9.3 Blood Tests for Alzheimer's Diagnosis Midstream Analysis
9.4 Blood Tests for Alzheimer's Diagnosis Downstream Analysis
10 RESEARCH FINDINGS AND CONCLUSION
11 APPENDIX
11.1 Methodology
11.2 Research Process and Data Source
11.3 Disclaimer
1.1 Blood Tests for Alzheimer's Diagnosis Introduction
1.2 World Blood Tests for Alzheimer's Diagnosis Market Size & Forecast (2021 & 2025 & 2032)
1.3 World Blood Tests for Alzheimer's Diagnosis Total Market by Region (by Headquarter Location)
1.3.1 World Blood Tests for Alzheimer's Diagnosis Market Size by Region (2021-2032), (by Headquarter Location)
1.3.2 United States Based Company Blood Tests for Alzheimer's Diagnosis Revenue (2021-2032)
1.3.3 China Based Company Blood Tests for Alzheimer's Diagnosis Revenue (2021-2032)
1.3.4 Europe Based Company Blood Tests for Alzheimer's Diagnosis Revenue (2021-2032)
1.3.5 Japan Based Company Blood Tests for Alzheimer's Diagnosis Revenue (2021-2032)
1.3.6 South Korea Based Company Blood Tests for Alzheimer's Diagnosis Revenue (2021-2032)
1.3.7 ASEAN Based Company Blood Tests for Alzheimer's Diagnosis Revenue (2021-2032)
1.3.8 India Based Company Blood Tests for Alzheimer's Diagnosis Revenue (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 Blood Tests for Alzheimer's Diagnosis Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Major Market Trends
2 DEMAND SUMMARY
2.1 World Blood Tests for Alzheimer's Diagnosis Consumption Value (2021-2032)
2.2 World Blood Tests for Alzheimer's Diagnosis Consumption Value by Region
2.2.1 World Blood Tests for Alzheimer's Diagnosis Consumption Value by Region (2021-2026)
2.2.2 World Blood Tests for Alzheimer's Diagnosis Consumption Value Forecast by Region (2027-2032)
2.3 United States Blood Tests for Alzheimer's Diagnosis Consumption Value (2021-2032)
2.4 China Blood Tests for Alzheimer's Diagnosis Consumption Value (2021-2032)
2.5 Europe Blood Tests for Alzheimer's Diagnosis Consumption Value (2021-2032)
2.6 Japan Blood Tests for Alzheimer's Diagnosis Consumption Value (2021-2032)
2.7 South Korea Blood Tests for Alzheimer's Diagnosis Consumption Value (2021-2032)
2.8 ASEAN Blood Tests for Alzheimer's Diagnosis Consumption Value (2021-2032)
2.9 India Blood Tests for Alzheimer's Diagnosis Consumption Value (2021-2032)
3 WORLD BLOOD TESTS FOR ALZHEIMER'S DIAGNOSIS COMPANIES COMPETITIVE ANALYSIS
3.1 World Blood Tests for Alzheimer's Diagnosis Revenue by Player (2021-2026)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Blood Tests for Alzheimer's Diagnosis Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Blood Tests for Alzheimer's Diagnosis in 2025
3.2.3 Global Concentration Ratios (CR8) for Blood Tests for Alzheimer's Diagnosis in 2025
3.3 Blood Tests for Alzheimer's Diagnosis Company Evaluation Quadrant
3.4 Blood Tests for Alzheimer's Diagnosis Market: Overall Company Footprint Analysis
3.4.1 Blood Tests for Alzheimer's Diagnosis Market: Region Footprint
3.4.2 Blood Tests for Alzheimer's Diagnosis Market: Company Product Type Footprint
3.4.3 Blood Tests for Alzheimer's Diagnosis Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers & Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: Blood Tests for Alzheimer's Diagnosis Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Blood Tests for Alzheimer's Diagnosis Revenue Comparison (2021 & 2025 & 2032) (by Headquarter Location)
4.1.2 United States VS China: Blood Tests for Alzheimer's Diagnosis Revenue Market Share Comparison (2021 & 2025 & 2032)
4.2 United States Based Companies VS China Based Companies: Blood Tests for Alzheimer's Diagnosis Consumption Value Comparison
4.2.1 United States VS China: Blood Tests for Alzheimer's Diagnosis Consumption Value Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: Blood Tests for Alzheimer's Diagnosis Consumption Value Market Share Comparison (2021 & 2025 & 2032)
4.3 United States Based Blood Tests for Alzheimer's Diagnosis Companies and Market Share, 2021-2026
4.3.1 United States Based Blood Tests for Alzheimer's Diagnosis Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Blood Tests for Alzheimer's Diagnosis Revenue, (2021-2026)
4.4 China Based Companies Blood Tests for Alzheimer's Diagnosis Revenue and Market Share, 2021-2026
4.4.1 China Based Blood Tests for Alzheimer's Diagnosis Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Blood Tests for Alzheimer's Diagnosis Revenue, (2021-2026)
4.5 Rest of World Based Blood Tests for Alzheimer's Diagnosis Companies and Market Share, 2021-2026
4.5.1 Rest of World Based Blood Tests for Alzheimer's Diagnosis Companies, Headquarters (Province, Country)
4.5.2 Rest of World Based Companies Blood Tests for Alzheimer's Diagnosis Revenue (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World Blood Tests for Alzheimer's Diagnosis Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 Single Biomarker Tests
5.2.2 Multi-Biomarker Panel Tests
5.2.3 Others
5.3 Market Segment by Type
5.3.1 World Blood Tests for Alzheimer's Diagnosis Market Size by Type (2021-2026)
5.3.2 World Blood Tests for Alzheimer's Diagnosis Market Size by Type (2027-2032)
5.3.3 World Blood Tests for Alzheimer's Diagnosis Market Size Market Share by Type (2027-2032)
6 MARKET ANALYSIS COMMERCIALIZATION STATUS
6.1 World Blood Tests for Alzheimer's Diagnosis Market Size Overview Commercialization Status: 2021 VS 2025 VS 2032
6.2 Segment Introduction Commercialization Status
6.2.1 Chemiluminescent Immunoassay
6.2.2 Single-Molecule and Ultra-Sensitive Immunoassay
6.2.3 Mass Spectrometry-Based Testing
6.2.4 Others
6.3 Market Segment Commercialization Status
6.3.1 World Blood Tests for Alzheimer's Diagnosis Market Size Commercialization Status (2021-2026)
6.3.2 World Blood Tests for Alzheimer's Diagnosis Market Size Commercialization Status (2027-2032)
6.3.3 World Blood Tests for Alzheimer's Diagnosis Market Size Market Share Commercialization Status (2027-2032)
7 MARKET ANALYSIS BY APPLICATION
7.1 World Blood Tests for Alzheimer's Diagnosis Market Size Overview by Application: 2021 VS 2025 VS 2032
7.2 Segment Introduction by Application
7.2.1 Clinical Use
7.2.2 Non-Clinical Use
7.3 Market Segment by Application
7.3.1 World Blood Tests for Alzheimer's Diagnosis Market Size by Application (2021-2026)
7.3.2 World Blood Tests for Alzheimer's Diagnosis Market Size by Application (2027-2032)
7.3.3 World Blood Tests for Alzheimer's Diagnosis Market Size Market Share by Application (2021-2032)
8 COMPANY PROFILES
8.1 Roche
8.1.1 Roche Details
8.1.2 Roche Major Business
8.1.3 Roche Blood Tests for Alzheimer's Diagnosis Product and Services
8.1.4 Roche Blood Tests for Alzheimer's Diagnosis Revenue, Gross Margin and Market Share (2021-2026)
8.1.5 Roche Recent Developments/Updates
8.1.6 Roche Competitive Strengths & Weaknesses
8.2 Fujirebio
8.2.1 Fujirebio Details
8.2.2 Fujirebio Major Business
8.2.3 Fujirebio Blood Tests for Alzheimer's Diagnosis Product and Services
8.2.4 Fujirebio Blood Tests for Alzheimer's Diagnosis Revenue, Gross Margin and Market Share (2021-2026)
8.2.5 Fujirebio Recent Developments/Updates
8.2.6 Fujirebio Competitive Strengths & Weaknesses
8.3 Sysmex
8.3.1 Sysmex Details
8.3.2 Sysmex Major Business
8.3.3 Sysmex Blood Tests for Alzheimer's Diagnosis Product and Services
8.3.4 Sysmex Blood Tests for Alzheimer's Diagnosis Revenue, Gross Margin and Market Share (2021-2026)
8.3.5 Sysmex Recent Developments/Updates
8.3.6 Sysmex Competitive Strengths & Weaknesses
8.4 Shimadzu
8.4.1 Shimadzu Details
8.4.2 Shimadzu Major Business
8.4.3 Shimadzu Blood Tests for Alzheimer's Diagnosis Product and Services
8.4.4 Shimadzu Blood Tests for Alzheimer's Diagnosis Revenue, Gross Margin and Market Share (2021-2026)
8.4.5 Shimadzu Recent Developments/Updates
8.4.6 Shimadzu Competitive Strengths & Weaknesses
8.5 Diadem
8.5.1 Diadem Details
8.5.2 Diadem Major Business
8.5.3 Diadem Blood Tests for Alzheimer's Diagnosis Product and Services
8.5.4 Diadem Blood Tests for Alzheimer's Diagnosis Revenue, Gross Margin and Market Share (2021-2026)
8.5.5 Diadem Recent Developments/Updates
8.5.6 Diadem Competitive Strengths & Weaknesses
8.6 Quanterix
8.6.1 Quanterix Details
8.6.2 Quanterix Major Business
8.6.3 Quanterix Blood Tests for Alzheimer's Diagnosis Product and Services
8.6.4 Quanterix Blood Tests for Alzheimer's Diagnosis Revenue, Gross Margin and Market Share (2021-2026)
8.6.5 Quanterix Recent Developments/Updates
8.6.6 Quanterix Competitive Strengths & Weaknesses
8.7 ALZpath
8.7.1 ALZpath Details
8.7.2 ALZpath Major Business
8.7.3 ALZpath Blood Tests for Alzheimer's Diagnosis Product and Services
8.7.4 ALZpath Blood Tests for Alzheimer's Diagnosis Revenue, Gross Margin and Market Share (2021-2026)
8.7.5 ALZpath Recent Developments/Updates
8.7.6 ALZpath Competitive Strengths & Weaknesses
8.8 Beckman Coulter Diagnostics
8.8.1 Beckman Coulter Diagnostics Details
8.8.2 Beckman Coulter Diagnostics Major Business
8.8.3 Beckman Coulter Diagnostics Blood Tests for Alzheimer's Diagnosis Product and Services
8.8.4 Beckman Coulter Diagnostics Blood Tests for Alzheimer's Diagnosis Revenue, Gross Margin and Market Share (2021-2026)
8.8.5 Beckman Coulter Diagnostics Recent Developments/Updates
8.8.6 Beckman Coulter Diagnostics Competitive Strengths & Weaknesses
8.9 Siemens Healthineers
8.9.1 Siemens Healthineers Details
8.9.2 Siemens Healthineers Major Business
8.9.3 Siemens Healthineers Blood Tests for Alzheimer's Diagnosis Product and Services
8.9.4 Siemens Healthineers Blood Tests for Alzheimer's Diagnosis Revenue, Gross Margin and Market Share (2021-2026)
8.9.5 Siemens Healthineers Recent Developments/Updates
8.9.6 Siemens Healthineers Competitive Strengths & Weaknesses
8.10 Vazyme
8.10.1 Vazyme Details
8.10.2 Vazyme Major Business
8.10.3 Vazyme Blood Tests for Alzheimer's Diagnosis Product and Services
8.10.4 Vazyme Blood Tests for Alzheimer's Diagnosis Revenue, Gross Margin and Market Share (2021-2026)
8.10.5 Vazyme Recent Developments/Updates
8.10.6 Vazyme Competitive Strengths & Weaknesses
8.11 Hoyotek
8.11.1 Hoyotek Details
8.11.2 Hoyotek Major Business
8.11.3 Hoyotek Blood Tests for Alzheimer's Diagnosis Product and Services
8.11.4 Hoyotek Blood Tests for Alzheimer's Diagnosis Revenue, Gross Margin and Market Share (2021-2026)
8.11.5 Hoyotek Recent Developments/Updates
8.11.6 Hoyotek Competitive Strengths & Weaknesses
8.12 BGI Genomics
8.12.1 BGI Genomics Details
8.12.2 BGI Genomics Major Business
8.12.3 BGI Genomics Blood Tests for Alzheimer's Diagnosis Product and Services
8.12.4 BGI Genomics Blood Tests for Alzheimer's Diagnosis Revenue, Gross Margin and Market Share (2021-2026)
8.12.5 BGI Genomics Recent Developments/Updates
8.12.6 BGI Genomics Competitive Strengths & Weaknesses
8.13 Kemei Diagnostics
8.13.1 Kemei Diagnostics Details
8.13.2 Kemei Diagnostics Major Business
8.13.3 Kemei Diagnostics Blood Tests for Alzheimer's Diagnosis Product and Services
8.13.4 Kemei Diagnostics Blood Tests for Alzheimer's Diagnosis Revenue, Gross Margin and Market Share (2021-2026)
8.13.5 Kemei Diagnostics Recent Developments/Updates
8.13.6 Kemei Diagnostics Competitive Strengths & Weaknesses
8.14 Maya Lightyear
8.14.1 Maya Lightyear Details
8.14.2 Maya Lightyear Major Business
8.14.3 Maya Lightyear Blood Tests for Alzheimer's Diagnosis Product and Services
8.14.4 Maya Lightyear Blood Tests for Alzheimer's Diagnosis Revenue, Gross Margin and Market Share (2021-2026)
8.14.5 Maya Lightyear Recent Developments/Updates
8.14.6 Maya Lightyear Competitive Strengths & Weaknesses
9 INDUSTRY CHAIN ANALYSIS
9.1 Blood Tests for Alzheimer's Diagnosis Industry Chain
9.2 Blood Tests for Alzheimer's Diagnosis Upstream Analysis
9.3 Blood Tests for Alzheimer's Diagnosis Midstream Analysis
9.4 Blood Tests for Alzheimer's Diagnosis Downstream Analysis
10 RESEARCH FINDINGS AND CONCLUSION
11 APPENDIX
11.1 Methodology
11.2 Research Process and Data Source
11.3 Disclaimer
LIST OF TABLES
Table 1. World Blood Tests for Alzheimer's Diagnosis Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Table 2. World Blood Tests for Alzheimer's Diagnosis Revenue by Region (2021-2026) & (USD Million), (by Headquarter Location)
Table 3. World Blood Tests for Alzheimer's Diagnosis Revenue by Region (2027-2032) & (USD Million), (by Headquarter Location)
Table 4. World Blood Tests for Alzheimer's Diagnosis Revenue Market Share by Region (2021-2026), (by Headquarter Location)
Table 5. World Blood Tests for Alzheimer's Diagnosis Revenue Market Share by Region (2027-2032), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Blood Tests for Alzheimer's Diagnosis Consumption Value Growth Rate Forecast by Region (2021 & 2025 & 2032) & (USD Million)
Table 8. World Blood Tests for Alzheimer's Diagnosis Consumption Value by Region (2021-2026) & (USD Million)
Table 9. World Blood Tests for Alzheimer's Diagnosis Consumption Value Forecast by Region (2027-2032) & (USD Million)
Table 10. World Blood Tests for Alzheimer's Diagnosis Revenue by Player (2021-2026) & (USD Million)
Table 11. Revenue Market Share of Key Blood Tests for Alzheimer's Diagnosis Players in 2025
Table 12. World Blood Tests for Alzheimer's Diagnosis Industry Rank of Major Player, Based on Revenue in 2025
Table 13. Global Blood Tests for Alzheimer's Diagnosis Company Evaluation Quadrant
Table 14. Head Office of Key Blood Tests for Alzheimer's Diagnosis Players
Table 15. Blood Tests for Alzheimer's Diagnosis Market: Company Product Type Footprint
Table 16. Blood Tests for Alzheimer's Diagnosis Market: Company Product Application Footprint
Table 17. Blood Tests for Alzheimer's Diagnosis Mergers & Acquisitions Activity
Table 18. United States VS China Blood Tests for Alzheimer's Diagnosis Revenue Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 19. United States VS China Blood Tests for Alzheimer's Diagnosis Consumption Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 20. United States Based Blood Tests for Alzheimer's Diagnosis Companies, Headquarters (States, Country)
Table 21. United States Based Companies Blood Tests for Alzheimer's Diagnosis Revenue, (2021-2026) & (USD Million)
Table 22. United States Based Companies Blood Tests for Alzheimer's Diagnosis Revenue Market Share (2021-2026)
Table 23. China Based Blood Tests for Alzheimer's Diagnosis Companies, Headquarters (Province, Country)
Table 24. China Based Companies Blood Tests for Alzheimer's Diagnosis Revenue, (2021-2026) & (USD Million)
Table 25. China Based Companies Blood Tests for Alzheimer's Diagnosis Revenue Market Share (2021-2026)
Table 26. Rest of World Based Blood Tests for Alzheimer's Diagnosis Companies, Headquarters (Province, Country)
Table 27. Rest of World Based Companies Blood Tests for Alzheimer's Diagnosis Revenue (2021-2026) & (USD Million)
Table 28. Rest of World Based Companies Blood Tests for Alzheimer's Diagnosis Revenue Market Share (2021-2026)
Table 29. World Blood Tests for Alzheimer's Diagnosis Market Size by Type, (USD Million), 2021 & 2025 & 2032
Table 30. World Blood Tests for Alzheimer's Diagnosis Market Size Value by Type (2021-2026) & (USD Million)
Table 31. World Blood Tests for Alzheimer's Diagnosis Market Size by Type (2027-2032) & (USD Million)
Table 32. World Blood Tests for Alzheimer's Diagnosis Market Size Commercialization Status, (USD Million), 2021 & 2025 & 2032
Table 33. World Blood Tests for Alzheimer's Diagnosis Market Size Value Commercialization Status (2021-2026) & (USD Million)
Table 34. World Blood Tests for Alzheimer's Diagnosis Market Size Commercialization Status (2027-2032) & (USD Million)
Table 35. World Blood Tests for Alzheimer's Diagnosis Market Size by Application, (USD Million), 2021 & 2025 & 2032
Table 36. World Blood Tests for Alzheimer's Diagnosis Market Size by Application (2021-2026) & (USD Million)
Table 37. World Blood Tests for Alzheimer's Diagnosis Market Size by Application (2027-2032) & (USD Million)
Table 38. Roche Basic Information, Manufacturing Base and Competitors
Table 39. Roche Major Business
Table 40. Roche Blood Tests for Alzheimer's Diagnosis Product and Services
Table 41. Roche Blood Tests for Alzheimer's Diagnosis Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 42. Roche Recent Developments/Updates
Table 43. Roche Competitive Strengths & Weaknesses
Table 44. Fujirebio Basic Information, Manufacturing Base and Competitors
Table 45. Fujirebio Major Business
Table 46. Fujirebio Blood Tests for Alzheimer's Diagnosis Product and Services
Table 47. Fujirebio Blood Tests for Alzheimer's Diagnosis Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 48. Fujirebio Recent Developments/Updates
Table 49. Fujirebio Competitive Strengths & Weaknesses
Table 50. Sysmex Basic Information, Manufacturing Base and Competitors
Table 51. Sysmex Major Business
Table 52. Sysmex Blood Tests for Alzheimer's Diagnosis Product and Services
Table 53. Sysmex Blood Tests for Alzheimer's Diagnosis Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 54. Sysmex Recent Developments/Updates
Table 55. Sysmex Competitive Strengths & Weaknesses
Table 56. Shimadzu Basic Information, Manufacturing Base and Competitors
Table 57. Shimadzu Major Business
Table 58. Shimadzu Blood Tests for Alzheimer's Diagnosis Product and Services
Table 59. Shimadzu Blood Tests for Alzheimer's Diagnosis Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 60. Shimadzu Recent Developments/Updates
Table 61. Shimadzu Competitive Strengths & Weaknesses
Table 62. Diadem Basic Information, Manufacturing Base and Competitors
Table 63. Diadem Major Business
Table 64. Diadem Blood Tests for Alzheimer's Diagnosis Product and Services
Table 65. Diadem Blood Tests for Alzheimer's Diagnosis Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 66. Diadem Recent Developments/Updates
Table 67. Diadem Competitive Strengths & Weaknesses
Table 68. Quanterix Basic Information, Manufacturing Base and Competitors
Table 69. Quanterix Major Business
Table 70. Quanterix Blood Tests for Alzheimer's Diagnosis Product and Services
Table 71. Quanterix Blood Tests for Alzheimer's Diagnosis Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 72. Quanterix Recent Developments/Updates
Table 73. Quanterix Competitive Strengths & Weaknesses
Table 74. ALZpath Basic Information, Manufacturing Base and Competitors
Table 75. ALZpath Major Business
Table 76. ALZpath Blood Tests for Alzheimer's Diagnosis Product and Services
Table 77. ALZpath Blood Tests for Alzheimer's Diagnosis Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 78. ALZpath Recent Developments/Updates
Table 79. ALZpath Competitive Strengths & Weaknesses
Table 80. Beckman Coulter Diagnostics Basic Information, Manufacturing Base and Competitors
Table 81. Beckman Coulter Diagnostics Major Business
Table 82. Beckman Coulter Diagnostics Blood Tests for Alzheimer's Diagnosis Product and Services
Table 83. Beckman Coulter Diagnostics Blood Tests for Alzheimer's Diagnosis Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 84. Beckman Coulter Diagnostics Recent Developments/Updates
Table 85. Beckman Coulter Diagnostics Competitive Strengths & Weaknesses
Table 86. Siemens Healthineers Basic Information, Manufacturing Base and Competitors
Table 87. Siemens Healthineers Major Business
Table 88. Siemens Healthineers Blood Tests for Alzheimer's Diagnosis Product and Services
Table 89. Siemens Healthineers Blood Tests for Alzheimer's Diagnosis Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 90. Siemens Healthineers Recent Developments/Updates
Table 91. Siemens Healthineers Competitive Strengths & Weaknesses
Table 92. Vazyme Basic Information, Manufacturing Base and Competitors
Table 93. Vazyme Major Business
Table 94. Vazyme Blood Tests for Alzheimer's Diagnosis Product and Services
Table 95. Vazyme Blood Tests for Alzheimer's Diagnosis Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 96. Vazyme Recent Developments/Updates
Table 97. Vazyme Competitive Strengths & Weaknesses
Table 98. Hoyotek Basic Information, Manufacturing Base and Competitors
Table 99. Hoyotek Major Business
Table 100. Hoyotek Blood Tests for Alzheimer's Diagnosis Product and Services
Table 101. Hoyotek Blood Tests for Alzheimer's Diagnosis Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 102. Hoyotek Recent Developments/Updates
Table 103. Hoyotek Competitive Strengths & Weaknesses
Table 104. BGI Genomics Basic Information, Manufacturing Base and Competitors
Table 105. BGI Genomics Major Business
Table 106. BGI Genomics Blood Tests for Alzheimer's Diagnosis Product and Services
Table 107. BGI Genomics Blood Tests for Alzheimer's Diagnosis Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 108. BGI Genomics Recent Developments/Updates
Table 109. BGI Genomics Competitive Strengths & Weaknesses
Table 110. Kemei Diagnostics Basic Information, Manufacturing Base and Competitors
Table 111. Kemei Diagnostics Major Business
Table 112. Kemei Diagnostics Blood Tests for Alzheimer's Diagnosis Product and Services
Table 113. Kemei Diagnostics Blood Tests for Alzheimer's Diagnosis Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 114. Kemei Diagnostics Recent Developments/Updates
Table 115. Kemei Diagnostics Competitive Strengths & Weaknesses
Table 116. Maya Lightyear Basic Information, Manufacturing Base and Competitors
Table 117. Maya Lightyear Major Business
Table 118. Maya Lightyear Blood Tests for Alzheimer's Diagnosis Product and Services
Table 119. Maya Lightyear Blood Tests for Alzheimer's Diagnosis Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 120. Maya Lightyear Recent Developments/Updates
Table 121. Maya Lightyear Competitive Strengths & Weaknesses
Table 122. Global Key Players of Blood Tests for Alzheimer's Diagnosis Upstream (Raw Materials)
Table 123. Global Blood Tests for Alzheimer's Diagnosis Typical Customers
Table 1. World Blood Tests for Alzheimer's Diagnosis Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Table 2. World Blood Tests for Alzheimer's Diagnosis Revenue by Region (2021-2026) & (USD Million), (by Headquarter Location)
Table 3. World Blood Tests for Alzheimer's Diagnosis Revenue by Region (2027-2032) & (USD Million), (by Headquarter Location)
Table 4. World Blood Tests for Alzheimer's Diagnosis Revenue Market Share by Region (2021-2026), (by Headquarter Location)
Table 5. World Blood Tests for Alzheimer's Diagnosis Revenue Market Share by Region (2027-2032), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Blood Tests for Alzheimer's Diagnosis Consumption Value Growth Rate Forecast by Region (2021 & 2025 & 2032) & (USD Million)
Table 8. World Blood Tests for Alzheimer's Diagnosis Consumption Value by Region (2021-2026) & (USD Million)
Table 9. World Blood Tests for Alzheimer's Diagnosis Consumption Value Forecast by Region (2027-2032) & (USD Million)
Table 10. World Blood Tests for Alzheimer's Diagnosis Revenue by Player (2021-2026) & (USD Million)
Table 11. Revenue Market Share of Key Blood Tests for Alzheimer's Diagnosis Players in 2025
Table 12. World Blood Tests for Alzheimer's Diagnosis Industry Rank of Major Player, Based on Revenue in 2025
Table 13. Global Blood Tests for Alzheimer's Diagnosis Company Evaluation Quadrant
Table 14. Head Office of Key Blood Tests for Alzheimer's Diagnosis Players
Table 15. Blood Tests for Alzheimer's Diagnosis Market: Company Product Type Footprint
Table 16. Blood Tests for Alzheimer's Diagnosis Market: Company Product Application Footprint
Table 17. Blood Tests for Alzheimer's Diagnosis Mergers & Acquisitions Activity
Table 18. United States VS China Blood Tests for Alzheimer's Diagnosis Revenue Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 19. United States VS China Blood Tests for Alzheimer's Diagnosis Consumption Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 20. United States Based Blood Tests for Alzheimer's Diagnosis Companies, Headquarters (States, Country)
Table 21. United States Based Companies Blood Tests for Alzheimer's Diagnosis Revenue, (2021-2026) & (USD Million)
Table 22. United States Based Companies Blood Tests for Alzheimer's Diagnosis Revenue Market Share (2021-2026)
Table 23. China Based Blood Tests for Alzheimer's Diagnosis Companies, Headquarters (Province, Country)
Table 24. China Based Companies Blood Tests for Alzheimer's Diagnosis Revenue, (2021-2026) & (USD Million)
Table 25. China Based Companies Blood Tests for Alzheimer's Diagnosis Revenue Market Share (2021-2026)
Table 26. Rest of World Based Blood Tests for Alzheimer's Diagnosis Companies, Headquarters (Province, Country)
Table 27. Rest of World Based Companies Blood Tests for Alzheimer's Diagnosis Revenue (2021-2026) & (USD Million)
Table 28. Rest of World Based Companies Blood Tests for Alzheimer's Diagnosis Revenue Market Share (2021-2026)
Table 29. World Blood Tests for Alzheimer's Diagnosis Market Size by Type, (USD Million), 2021 & 2025 & 2032
Table 30. World Blood Tests for Alzheimer's Diagnosis Market Size Value by Type (2021-2026) & (USD Million)
Table 31. World Blood Tests for Alzheimer's Diagnosis Market Size by Type (2027-2032) & (USD Million)
Table 32. World Blood Tests for Alzheimer's Diagnosis Market Size Commercialization Status, (USD Million), 2021 & 2025 & 2032
Table 33. World Blood Tests for Alzheimer's Diagnosis Market Size Value Commercialization Status (2021-2026) & (USD Million)
Table 34. World Blood Tests for Alzheimer's Diagnosis Market Size Commercialization Status (2027-2032) & (USD Million)
Table 35. World Blood Tests for Alzheimer's Diagnosis Market Size by Application, (USD Million), 2021 & 2025 & 2032
Table 36. World Blood Tests for Alzheimer's Diagnosis Market Size by Application (2021-2026) & (USD Million)
Table 37. World Blood Tests for Alzheimer's Diagnosis Market Size by Application (2027-2032) & (USD Million)
Table 38. Roche Basic Information, Manufacturing Base and Competitors
Table 39. Roche Major Business
Table 40. Roche Blood Tests for Alzheimer's Diagnosis Product and Services
Table 41. Roche Blood Tests for Alzheimer's Diagnosis Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 42. Roche Recent Developments/Updates
Table 43. Roche Competitive Strengths & Weaknesses
Table 44. Fujirebio Basic Information, Manufacturing Base and Competitors
Table 45. Fujirebio Major Business
Table 46. Fujirebio Blood Tests for Alzheimer's Diagnosis Product and Services
Table 47. Fujirebio Blood Tests for Alzheimer's Diagnosis Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 48. Fujirebio Recent Developments/Updates
Table 49. Fujirebio Competitive Strengths & Weaknesses
Table 50. Sysmex Basic Information, Manufacturing Base and Competitors
Table 51. Sysmex Major Business
Table 52. Sysmex Blood Tests for Alzheimer's Diagnosis Product and Services
Table 53. Sysmex Blood Tests for Alzheimer's Diagnosis Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 54. Sysmex Recent Developments/Updates
Table 55. Sysmex Competitive Strengths & Weaknesses
Table 56. Shimadzu Basic Information, Manufacturing Base and Competitors
Table 57. Shimadzu Major Business
Table 58. Shimadzu Blood Tests for Alzheimer's Diagnosis Product and Services
Table 59. Shimadzu Blood Tests for Alzheimer's Diagnosis Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 60. Shimadzu Recent Developments/Updates
Table 61. Shimadzu Competitive Strengths & Weaknesses
Table 62. Diadem Basic Information, Manufacturing Base and Competitors
Table 63. Diadem Major Business
Table 64. Diadem Blood Tests for Alzheimer's Diagnosis Product and Services
Table 65. Diadem Blood Tests for Alzheimer's Diagnosis Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 66. Diadem Recent Developments/Updates
Table 67. Diadem Competitive Strengths & Weaknesses
Table 68. Quanterix Basic Information, Manufacturing Base and Competitors
Table 69. Quanterix Major Business
Table 70. Quanterix Blood Tests for Alzheimer's Diagnosis Product and Services
Table 71. Quanterix Blood Tests for Alzheimer's Diagnosis Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 72. Quanterix Recent Developments/Updates
Table 73. Quanterix Competitive Strengths & Weaknesses
Table 74. ALZpath Basic Information, Manufacturing Base and Competitors
Table 75. ALZpath Major Business
Table 76. ALZpath Blood Tests for Alzheimer's Diagnosis Product and Services
Table 77. ALZpath Blood Tests for Alzheimer's Diagnosis Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 78. ALZpath Recent Developments/Updates
Table 79. ALZpath Competitive Strengths & Weaknesses
Table 80. Beckman Coulter Diagnostics Basic Information, Manufacturing Base and Competitors
Table 81. Beckman Coulter Diagnostics Major Business
Table 82. Beckman Coulter Diagnostics Blood Tests for Alzheimer's Diagnosis Product and Services
Table 83. Beckman Coulter Diagnostics Blood Tests for Alzheimer's Diagnosis Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 84. Beckman Coulter Diagnostics Recent Developments/Updates
Table 85. Beckman Coulter Diagnostics Competitive Strengths & Weaknesses
Table 86. Siemens Healthineers Basic Information, Manufacturing Base and Competitors
Table 87. Siemens Healthineers Major Business
Table 88. Siemens Healthineers Blood Tests for Alzheimer's Diagnosis Product and Services
Table 89. Siemens Healthineers Blood Tests for Alzheimer's Diagnosis Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 90. Siemens Healthineers Recent Developments/Updates
Table 91. Siemens Healthineers Competitive Strengths & Weaknesses
Table 92. Vazyme Basic Information, Manufacturing Base and Competitors
Table 93. Vazyme Major Business
Table 94. Vazyme Blood Tests for Alzheimer's Diagnosis Product and Services
Table 95. Vazyme Blood Tests for Alzheimer's Diagnosis Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 96. Vazyme Recent Developments/Updates
Table 97. Vazyme Competitive Strengths & Weaknesses
Table 98. Hoyotek Basic Information, Manufacturing Base and Competitors
Table 99. Hoyotek Major Business
Table 100. Hoyotek Blood Tests for Alzheimer's Diagnosis Product and Services
Table 101. Hoyotek Blood Tests for Alzheimer's Diagnosis Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 102. Hoyotek Recent Developments/Updates
Table 103. Hoyotek Competitive Strengths & Weaknesses
Table 104. BGI Genomics Basic Information, Manufacturing Base and Competitors
Table 105. BGI Genomics Major Business
Table 106. BGI Genomics Blood Tests for Alzheimer's Diagnosis Product and Services
Table 107. BGI Genomics Blood Tests for Alzheimer's Diagnosis Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 108. BGI Genomics Recent Developments/Updates
Table 109. BGI Genomics Competitive Strengths & Weaknesses
Table 110. Kemei Diagnostics Basic Information, Manufacturing Base and Competitors
Table 111. Kemei Diagnostics Major Business
Table 112. Kemei Diagnostics Blood Tests for Alzheimer's Diagnosis Product and Services
Table 113. Kemei Diagnostics Blood Tests for Alzheimer's Diagnosis Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 114. Kemei Diagnostics Recent Developments/Updates
Table 115. Kemei Diagnostics Competitive Strengths & Weaknesses
Table 116. Maya Lightyear Basic Information, Manufacturing Base and Competitors
Table 117. Maya Lightyear Major Business
Table 118. Maya Lightyear Blood Tests for Alzheimer's Diagnosis Product and Services
Table 119. Maya Lightyear Blood Tests for Alzheimer's Diagnosis Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 120. Maya Lightyear Recent Developments/Updates
Table 121. Maya Lightyear Competitive Strengths & Weaknesses
Table 122. Global Key Players of Blood Tests for Alzheimer's Diagnosis Upstream (Raw Materials)
Table 123. Global Blood Tests for Alzheimer's Diagnosis Typical Customers
LIST OF FIGURES
Figure 1. Blood Tests for Alzheimer's Diagnosis Picture
Figure 2. World Blood Tests for Alzheimer's Diagnosis Total Revenue: 2021 & 2025 & 2032, (USD Million)
Figure 3. World Blood Tests for Alzheimer's Diagnosis Total Revenue (2021-2032) & (USD Million)
Figure 4. World Blood Tests for Alzheimer's Diagnosis Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Figure 5. World Blood Tests for Alzheimer's Diagnosis Revenue Market Share by Region (2021-2032), (by Headquarter Location)
Figure 6. United States Based Company Blood Tests for Alzheimer's Diagnosis Revenue (2021-2032) & (USD Million)
Figure 7. China Based Company Blood Tests for Alzheimer's Diagnosis Revenue (2021-2032) & (USD Million)
Figure 8. Europe Based Company Blood Tests for Alzheimer's Diagnosis Revenue (2021-2032) & (USD Million)
Figure 9. Japan Based Company Blood Tests for Alzheimer's Diagnosis Revenue (2021-2032) & (USD Million)
Figure 10. South Korea Based Company Blood Tests for Alzheimer's Diagnosis Revenue (2021-2032) & (USD Million)
Figure 11. ASEAN Based Company Blood Tests for Alzheimer's Diagnosis Revenue (2021-2032) & (USD Million)
Figure 12. India Based Company Blood Tests for Alzheimer's Diagnosis Revenue (2021-2032) & (USD Million)
Figure 13. Blood Tests for Alzheimer's Diagnosis Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Blood Tests for Alzheimer's Diagnosis Consumption Value (2021-2032) & (USD Million)
Figure 16. World Blood Tests for Alzheimer's Diagnosis Consumption Value Market Share by Region (2021-2032)
Figure 17. United States Blood Tests for Alzheimer's Diagnosis Consumption Value (2021-2032) & (USD Million)
Figure 18. China Blood Tests for Alzheimer's Diagnosis Consumption Value (2021-2032) & (USD Million)
Figure 19. Europe Blood Tests for Alzheimer's Diagnosis Consumption Value (2021-2032) & (USD Million)
Figure 20. Japan Blood Tests for Alzheimer's Diagnosis Consumption Value (2021-2032) & (USD Million)
Figure 21. South Korea Blood Tests for Alzheimer's Diagnosis Consumption Value (2021-2032) & (USD Million)
Figure 22. ASEAN Blood Tests for Alzheimer's Diagnosis Consumption Value (2021-2032) & (USD Million)
Figure 23. India Blood Tests for Alzheimer's Diagnosis Consumption Value (2021-2032) & (USD Million)
Figure 24. Producer Shipments of Blood Tests for Alzheimer's Diagnosis by Player Revenue ($MM) and Market Share (%): 2025
Figure 25. Global Four-firm Concentration Ratios (CR4) for Blood Tests for Alzheimer's Diagnosis Markets in 2025
Figure 26. Global Four-firm Concentration Ratios (CR8) for Blood Tests for Alzheimer's Diagnosis Markets in 2025
Figure 27. United States VS China: Blood Tests for Alzheimer's Diagnosis Revenue Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States VS China: Blood Tests for Alzheimer's Diagnosis Consumption Value Market Share Comparison (2021 & 2025 & 2032)
Figure 29. World Blood Tests for Alzheimer's Diagnosis Market Size by Type, (USD Million), 2021 & 2025 & 2032
Figure 30. World Blood Tests for Alzheimer's Diagnosis Market Size Market Share by Type in 2025
Figure 31. Single Biomarker Tests
Figure 32. Multi-Biomarker Panel Tests
Figure 33. Others
Figure 34. World Blood Tests for Alzheimer's Diagnosis Market Size Market Share by Type (2021-2032)
Figure 35. World Blood Tests for Alzheimer's Diagnosis Market Size Commercialization Status, (USD Million), 2021 & 2025 & 2032
Figure 36. World Blood Tests for Alzheimer's Diagnosis Market Size Market Share Commercialization Status in 2025
Figure 37. Chemiluminescent Immunoassay
Figure 38. Single-Molecule and Ultra-Sensitive Immunoassay
Figure 39. Mass Spectrometry-Based Testing
Figure 40. Others
Figure 41. World Blood Tests for Alzheimer's Diagnosis Market Size Market Share Commercialization Status (2021-2032)
Figure 42. Commercialized Products
Figure 43. Products under Development or Registration
Figure 44. Research Use Only Products
Figure 45. World Blood Tests for Alzheimer's Diagnosis Market Size by Application, (USD Million), 2021 & 2025 & 2032
Figure 46. World Blood Tests for Alzheimer's Diagnosis Market Size Market Share by Application in 2025
Figure 47. Clinical Use
Figure 48. Non-Clinical Use
Figure 49. World Blood Tests for Alzheimer's Diagnosis Market Size Market Share by Application (2021-2032)
Figure 50. Blood Tests for Alzheimer's Diagnosis Industrial Chain
Figure 51. Methodology
Figure 52. Research Process and Data Source
Figure 1. Blood Tests for Alzheimer's Diagnosis Picture
Figure 2. World Blood Tests for Alzheimer's Diagnosis Total Revenue: 2021 & 2025 & 2032, (USD Million)
Figure 3. World Blood Tests for Alzheimer's Diagnosis Total Revenue (2021-2032) & (USD Million)
Figure 4. World Blood Tests for Alzheimer's Diagnosis Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Figure 5. World Blood Tests for Alzheimer's Diagnosis Revenue Market Share by Region (2021-2032), (by Headquarter Location)
Figure 6. United States Based Company Blood Tests for Alzheimer's Diagnosis Revenue (2021-2032) & (USD Million)
Figure 7. China Based Company Blood Tests for Alzheimer's Diagnosis Revenue (2021-2032) & (USD Million)
Figure 8. Europe Based Company Blood Tests for Alzheimer's Diagnosis Revenue (2021-2032) & (USD Million)
Figure 9. Japan Based Company Blood Tests for Alzheimer's Diagnosis Revenue (2021-2032) & (USD Million)
Figure 10. South Korea Based Company Blood Tests for Alzheimer's Diagnosis Revenue (2021-2032) & (USD Million)
Figure 11. ASEAN Based Company Blood Tests for Alzheimer's Diagnosis Revenue (2021-2032) & (USD Million)
Figure 12. India Based Company Blood Tests for Alzheimer's Diagnosis Revenue (2021-2032) & (USD Million)
Figure 13. Blood Tests for Alzheimer's Diagnosis Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Blood Tests for Alzheimer's Diagnosis Consumption Value (2021-2032) & (USD Million)
Figure 16. World Blood Tests for Alzheimer's Diagnosis Consumption Value Market Share by Region (2021-2032)
Figure 17. United States Blood Tests for Alzheimer's Diagnosis Consumption Value (2021-2032) & (USD Million)
Figure 18. China Blood Tests for Alzheimer's Diagnosis Consumption Value (2021-2032) & (USD Million)
Figure 19. Europe Blood Tests for Alzheimer's Diagnosis Consumption Value (2021-2032) & (USD Million)
Figure 20. Japan Blood Tests for Alzheimer's Diagnosis Consumption Value (2021-2032) & (USD Million)
Figure 21. South Korea Blood Tests for Alzheimer's Diagnosis Consumption Value (2021-2032) & (USD Million)
Figure 22. ASEAN Blood Tests for Alzheimer's Diagnosis Consumption Value (2021-2032) & (USD Million)
Figure 23. India Blood Tests for Alzheimer's Diagnosis Consumption Value (2021-2032) & (USD Million)
Figure 24. Producer Shipments of Blood Tests for Alzheimer's Diagnosis by Player Revenue ($MM) and Market Share (%): 2025
Figure 25. Global Four-firm Concentration Ratios (CR4) for Blood Tests for Alzheimer's Diagnosis Markets in 2025
Figure 26. Global Four-firm Concentration Ratios (CR8) for Blood Tests for Alzheimer's Diagnosis Markets in 2025
Figure 27. United States VS China: Blood Tests for Alzheimer's Diagnosis Revenue Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States VS China: Blood Tests for Alzheimer's Diagnosis Consumption Value Market Share Comparison (2021 & 2025 & 2032)
Figure 29. World Blood Tests for Alzheimer's Diagnosis Market Size by Type, (USD Million), 2021 & 2025 & 2032
Figure 30. World Blood Tests for Alzheimer's Diagnosis Market Size Market Share by Type in 2025
Figure 31. Single Biomarker Tests
Figure 32. Multi-Biomarker Panel Tests
Figure 33. Others
Figure 34. World Blood Tests for Alzheimer's Diagnosis Market Size Market Share by Type (2021-2032)
Figure 35. World Blood Tests for Alzheimer's Diagnosis Market Size Commercialization Status, (USD Million), 2021 & 2025 & 2032
Figure 36. World Blood Tests for Alzheimer's Diagnosis Market Size Market Share Commercialization Status in 2025
Figure 37. Chemiluminescent Immunoassay
Figure 38. Single-Molecule and Ultra-Sensitive Immunoassay
Figure 39. Mass Spectrometry-Based Testing
Figure 40. Others
Figure 41. World Blood Tests for Alzheimer's Diagnosis Market Size Market Share Commercialization Status (2021-2032)
Figure 42. Commercialized Products
Figure 43. Products under Development or Registration
Figure 44. Research Use Only Products
Figure 45. World Blood Tests for Alzheimer's Diagnosis Market Size by Application, (USD Million), 2021 & 2025 & 2032
Figure 46. World Blood Tests for Alzheimer's Diagnosis Market Size Market Share by Application in 2025
Figure 47. Clinical Use
Figure 48. Non-Clinical Use
Figure 49. World Blood Tests for Alzheimer's Diagnosis Market Size Market Share by Application (2021-2032)
Figure 50. Blood Tests for Alzheimer's Diagnosis Industrial Chain
Figure 51. Methodology
Figure 52. Research Process and Data Source
